Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present MyDx, Inc. (OTC: MYDX).

Full DD Report for MYDX

You must become a subscriber to view this report.


Recent News from (OTC: MYDX)

MYDX RECRUITS MR. CANNABIS GROUP TO OPERATE COMPANY
La Jolla, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- MyDx, Inc. ( OTC: MYDX ) (the “Company”), a leader in science based cannabis health technologies, is proud to announce that it has successfully recruited the Mr. Cannabis Group to operate the Company effective immediate...
Source: GlobeNewswire
Date: November, 13 2018 07:07
MyDx Analyzer to be Used in Large HIV Study by the University of Florida
SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -  MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the  CannaDx Analyzer , in the largest...
Source: GlobeNewswire
Date: September, 28 2018 08:00
MyDx Shareholder Update
A Leader in Science Based Cannabis Health Technologies Positioning for a Pharma Acquisition  San Diego, CA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MyDx, Inc. ( OTC: MYDX ), a leader in science based cannabis health technologies, has been working diligently...
Source: GlobeNewswire
Date: September, 21 2018 11:49
U.S. pot market could be worth $47B - RBC #2
In a note , RBC Capital Markets says that legal sales of marijuana in the U.S. are catching up to beer and wine, potentially reaching $47B in ten years, implying a 17% CAGR. More news on: MJ Holdings, Inc., MyDx, Inc., Mountain High Acquisitions Corp., Healthcare stocks news, Consumer sto...
Source: SeekingAlpha
Date: August, 22 2018 09:55
Weed firms set for bullish action ahead of start of Canada recreational pot market
Cannabis-related stocks may see broad buying today as they announce supply agreements with retail operations ahead of the launch of the adult-use recreational cannabis market in Canada on October 17. Cronos Group (NASDAQ: CRON ) and Tilray (NASDAQ: TLRY ) have already announced deals. Both a...
Source: SeekingAlpha
Date: August, 21 2018 08:07
5 of Today's Biggest Marijuana Stock Gainers - Thursday, August 16th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Thursday, August 16th including CV Sciences, Inc. (OTC:CVSI) and more... Affinor Growers Inc. (CSE:AFI) (OTC:RSSFF) Shares of Affinor Growers Inc. rose 16.38% on lower than average tradi...
Source: Daily Marijuana Observer
Date: August, 16 2018 20:03
Tilray up 20% on Citron touch
"Today is the day that everything has changed in Cannabis," tweets Andrew Left . "Real $$$ into space. Next to get support should be Tilray ( TLRY +19.8% )." More news on: Tilray, Inc., Horizons Marijuana Life Sciences Index ETF, Cannimed Therapeutics Inc., Consumer stocks news, Healthc...
Source: SeekingAlpha
Date: August, 15 2018 12:59
Significant portion of California pot failing safety tests
Cannabis consumers in California should be aware that they may be ingesting weed that lags state-sanctioned safety standards that went into effect July 1. More news on: Horizons Marijuana Life Sciences Index ETF, Cannimed Therapeutics Inc., Medical Marijuana, Inc., Healthcare stocks news, ...
Source: SeekingAlpha
Date: July, 31 2018 12:27
Ontario to allow private-sector sales of marijuana - Globe & Mail
While the government would still control distribution, private stores in Ontario would be allowed to sell cannabis once it becomes legal on October 17, according to the story . More news on: Horizons Marijuana Life Sciences Index ETF, Cannimed Therapeutics Inc., Medical Marijuana, Inc., C...
Source: SeekingAlpha
Date: July, 27 2018 07:47
GMP Securities outlines opportunities in U.S. cannabis
Current U.S. cannabis sales of $6B are already as large as what Canada might get to in 2022, says GMP Securities . Just looking at the 33 currently legal U.S. states, the team sees sales growing to $20B in 2022. That could rise to $50B under a federally legal scenario. More news on: Horiz...
Source: SeekingAlpha
Date: July, 24 2018 09:50

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.00180.0020.0020.00173,797,514
2018-12-130.00190.00180.0020.00172,697,122
2018-12-120.00210.0020.00210.00172,300,130
2018-12-110.00210.00210.00220.00171,768,900
2018-12-100.00210.00220.00220.0021761,857

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-141,309,3303,797,51434.4786Cover
2018-12-13569,3862,697,12221.1109Cover
2018-12-12250,0002,300,13010.8690Cover
2018-12-11833,2701,768,90047.1067Short
2018-12-1010,000761,8571.3126Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MYDX.


About MyDx, Inc. (OTC: MYDX)

Logo for MyDx, Inc. (OTC: MYDX)

MyDx, Inc. OTC: MYDX is a science and technology company based in San Diego, California whose mission is to empower people to live a healthier life by revealing the chemicals in what they eat, drink and inhale. The Company has developed MyDx, a portable analyzer that provides real time chemical analysis that fits in the palm of your hands. MyDx leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that are compatible with the MyDx App. For more information, please visit www.cdxlife.com.

 

 

 

Current Management

  • Daniel Yazbeck / CEO
    • Daniel Yazbeck is the founder, seed investor and creator of the MyDx Analyzer. Daniel founded the Yazbeck Consulting amp Investment Group in and is a seasoned entrepreneur and cashflow investor for over years. Daniel leverages nearly years of experience with Fortune , as a Scientist for Pfizer Pharmaceuticals specializing in Chemical R amp D technologies, and as a Strategic Market Developer for Panasonic, engineering new products and partnerships for the consumer electronics healthcare industry. Daniel holds a Master s Degree in Medicinal Chemistry from McGill University with a minor in Marketing, and has coauthored several world patents and research publications.
  • Robert Vigil / VP, Eng.
    • Rob Vigil is a highly experienced software manager and engineer who has created the MyDx App and has been with the company since . He has has over years of software development and management experience with both his own online companies and with fortune companies. He joined the MyDx team early on to help build and manage the foundational software to support the product. Rob s background includes being a lead developer and software manager in the U.S. NAVY, SAIC, Jacobs Laboratories, Boeing and Unidev. Over the course of his career, he has implemented and developed many state of the art system supporting U.S. National Defense including development of flight training simulator software for use by the U.S. Navy pilots. He was instrumental in both the management and deployment of many defense support systems in addition to the flight training simulators.
  • Nicholas Hadler / VP, Ops.
    • Mr. Hadler is one of the cofounders of CDx Inc and has been with the company from the very early stages in . He studied Economics at the University of California, Santa Barbara before pursuing his entrepreneurship career with Yazbeck Investments. Nick is a seasoned social media expert on all platforms, helping establish MyDx as one of the premiere cannabis social brands within the industry. His indepth expertise in the cannabis field and product development training under Mr. Yazbeck allowed him to play a critical role in creating the MyDx App that has topped iOS charts Currently, Nick has transitioned to the role of VP of Operations, helping optimize the company s sales systems and affiliate network, as well better manage the customer service processes and procedures in order to improve the total customer experience amp drive revenue growth. Mr. handler reports to CEO Daniel Yazbeck.
  • Daniel Yazbeck / Chairman, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
    • Daniel Yazbeck is the founder, seed investor and creator of the MyDx Analyzer. Daniel founded the Yazbeck Consulting amp Investment Group in and is a seasoned entrepreneur and cashflow investor for over years. Daniel leverages nearly years of experience with Fortune , as a Scientist for Pfizer Pharmaceuticals specializing in Chemical R amp D technologies, and as a Strategic Market Developer for Panasonic, engineering new products and partnerships for the consumer electronics healthcare industry. Daniel holds a Master s Degree in Medicinal Chemistry from McGill University with a minor in Marketing, and has coauthored several world patents and research publications.

Current Share Structure

  • Market Cap: $7,383,764 - 03/15/2018
  • Authorized: 10,000,000,000 - 02/28/2018
  • Issue and Outstanding: 1,893,272,792 - 02/28/2018
  • Float: 1,385,119,155 - 03/27/2017

 


Recent Filings from (OTC: MYDX)

Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 17 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 13 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017
Withdrawal of registration statement filed under the Securities Act
Filing Type: RWFiling Source: edgar
Filing Date: October, 19 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: October, 12 2017

 

 


Daily Technical Chart for (OTC: MYDX)

Daily Technical Chart for (OTC: MYDX)


Stay tuned for daily updates and more on (OTC: MYDX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MYDX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MYDX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MYDX and does not buy, sell, or trade any shares of MYDX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/